Back to Search Start Over

Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment

Authors :
Vaidya, Jayant S; https://orcid.org/0000-0003-1760-1278
Bulsara, Max
Baum, Michael
Tobias, Jeffrey S
Dedes, Konstantin J
Vaidya, Jayant S; https://orcid.org/0000-0003-1760-1278
Bulsara, Max
Baum, Michael
Tobias, Jeffrey S
Dedes, Konstantin J
Source :
Vaidya, Jayant S; Bulsara, Max; Baum, Michael; Tobias, Jeffrey S; Dedes, Konstantin J (2021). Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment. British Journal of Cancer, 124(9):1469-1474.
Publication Year :
2021

Abstract

SummaryIn the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.

Details

Database :
OAIster
Journal :
Vaidya, Jayant S; Bulsara, Max; Baum, Michael; Tobias, Jeffrey S; Dedes, Konstantin J (2021). Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment. British Journal of Cancer, 124(9):1469-1474.
Notes :
application/pdf, info:doi/10.5167/uzh-214039, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1443043002
Document Type :
Electronic Resource